Topics

Bone Biologics Corporation Company Profile

07:11 EDT 21st September 2019 | BioPortfolio


News Articles [1320 Associated News Articles listed on BioPortfolio]

Bone Score, Bone Markers, and Perimenopausal Bone Loss Risk

Find out how bone turnover markers and trabecular bone score can help in the early detection of bone loss. Clinical Endocrinology

Biologics Preserve Bone in PsA

(MedPage Today) -- No effect for methotrexate alone, however

Bone Graft Substitute Degrades Naturally as Bone Fractures Heal

ArticleResearchers have developed a moldable bone substitute called Novogro Putty that can be implanted into the site of a bone fracture and degrades as the bone naturally heals.

ORION CORPORATION: ACQUISITION OF OWN SHARES 10.05.2019

Orion Corporation NOTIFICATION 10.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 10.05.2019 Date 10.05.201...

ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019

Orion Corporation NOTIFICATION 09.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019 Date 09.05.20...

ORION CORPORATION: ACQUISITION OF OWN SHARES 06.05.2019

Orion Corporation NOTIFICATION 06.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 06.05.2019 Date 06.05.2...

ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019

Orion Corporation NOTIFICATION 02.05.2019 at 19:13 ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019 Date 02....

ORION CORPORATION: ACQUISITION OF OWN SHARES 08.05.2019

Orion Corporation NOTIFICATION 08.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 08.05.2019 Date 08.05.2019  ...

PubMed Articles [2125 Associated PubMed Articles listed on BioPortfolio]

Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have been associated with generalized and localized bone loss. We conducted a comprehensive study using imaging (dual-energy X-ray absorptiome...

Biosimilars in India; Current Status and Future Perspectives.

Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar ...

Cutaneous lymphomas appearing under biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Controversy exists regarding the risk and prognosis of lymphomas under biologics . Risk evaluation must consider the underlying medical condition -as chronic inflammatory diseases are associated with ...

Shifting paradigms revisited: biotechnology and the pharmaceutical sciences.

In 2003 Crommelin et al. published an article titled: 'Shifting paradigms: biopharmaceuticals versus low molecular weight drugs' (https://doi.org/10.1016/S0378-5173(03)00376-4). In the current comment...

The emergence of new biologics for severe asthma.

Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive treatment with inhaled and oral glucocorticoids. Biologics for severe asthma aim to reduce asthma-re...

Clinical Trials [3676 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

This registry on Tofacitinib and biologics (anti-integrin/anti-TNF) in the treatment of ulcerative colitis (UC) patients in Germany will extend the prospective documentation of safety issu...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Companies [721 Associated Companies listed on BioPortfolio]

Bone Biologics Corp.

Bone Biologics (OTCQB:BBLG) was founded to pursue regenerative medicine for bone.

Bone Biologics, Inc.

Velcura Therapeutics, Inc

Velcura Therapeutics™, Inc. is a leading biotechnology firm in the treatment of bone-related injuries and bone disorders. Velcura develops therapies directed at stimulating bone formation. Velcura c...

Lattice Biologics

Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regenerati...

Lattice Biologics Ltd.

Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regenerati...

More Information about "Bone Biologics Corporation" on BioPortfolio

We have published hundreds of Bone Biologics Corporation news stories on BioPortfolio along with dozens of Bone Biologics Corporation Clinical Trials and PubMed Articles about Bone Biologics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bone Biologics Corporation Companies in our database. You can also find out about relevant Bone Biologics Corporation Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record